114 related articles for article (PubMed ID: 17566133)
1. Synthesis and conformational analysis of macrocyclic dihydroxystilbenes linked between the para-para positions.
Mateo C; López V; Medarde M; Peláez R
Chemistry; 2007; 13(25):7246-56. PubMed ID: 17566133
[TBL] [Abstract][Full Text] [Related]
2. New para-para stilbenophanes: synthesis by McMurry coupling, conformational analysis and inhibition of tubulin polymerisation.
Álvarez R; López V; Mateo C; Medarde M; Peláez R
Chemistry; 2011 Mar; 17(12):3406-19. PubMed ID: 21344518
[TBL] [Abstract][Full Text] [Related]
3. Stilbenophane analogues of deoxycombretastatin A-4.
Mateo C; Pérez-Melero C; Peláez R; Medarde M
J Org Chem; 2005 Aug; 70(16):6544-7. PubMed ID: 16050729
[TBL] [Abstract][Full Text] [Related]
4. Conformationally restricted macrocyclic analogues of combretastatins.
Mateo C; Alvarez R; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem Lett; 2007 Nov; 17(22):6316-20. PubMed ID: 17889536
[TBL] [Abstract][Full Text] [Related]
5. p,p-Dihydroxydihydrostilbenophanes related to antimitotic combretastatins. Conformational analysis and its relationship to tubulin inhibition.
Álvarez R; López V; Mateo C; Medarde M; Peláez R
J Org Chem; 2014 Aug; 79(15):6840-57. PubMed ID: 24966024
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of double bond substituted combretastatins.
Hadfield JA; Gaukroger K; Hirst N; Weston AP; Lawrence NJ; McGown AT
Eur J Med Chem; 2005 Jun; 40(6):529-41. PubMed ID: 15922837
[TBL] [Abstract][Full Text] [Related]
7. Complete NMR data of methoxylated cis- and trans-stilbenes as well as 1,2-diphenylethanes.
Jo G; Hyun J; Hwang D; Lee YH; Koh D; Lim Y
Magn Reson Chem; 2011 Jun; 49(6):374-7. PubMed ID: 21452348
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic evaluation of combretafurans, potential scaffolds for dual-action antitumoral agents.
Pirali T; Busacca S; Beltrami L; Imovilli D; Pagliai F; Miglio G; Massarotti A; Verotta L; Tron GC; Sorba G; Genazzani AA
J Med Chem; 2006 Aug; 49(17):5372-6. PubMed ID: 16913727
[TBL] [Abstract][Full Text] [Related]
9. Antineoplastic agents. 579. Synthesis and cancer cell growth evaluation of E-stilstatin 3: a resveratrol structural modification.
Pettit GR; Melody N; Thornhill A; Knight JC; Groy TL; Herald CL
J Nat Prod; 2009 Sep; 72(9):1637-42. PubMed ID: 19719153
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activity of fluorinated combretastatin analogues.
Alloatti D; Giannini G; Cabri W; Lustrati I; Marzi M; Ciacci A; Gallo G; Tinti MO; Marcellini M; Riccioni T; Guglielmi MB; Carminati P; Pisano C
J Med Chem; 2008 May; 51(9):2708-21. PubMed ID: 18396857
[TBL] [Abstract][Full Text] [Related]
11. Further naphthylcombretastatins. An investigation on the role of the naphthalene moiety.
Maya AB; Pérez-Melero C; Mateo C; Alonso D; Fernández JL; Gajate C; Mollinedo F; Peláez R; Caballero E; Medarde M
J Med Chem; 2005 Jan; 48(2):556-68. PubMed ID: 15658869
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity, and inhibition of tubulin polymerization by conformationally restricted analogues of lavendustin A.
Mu F; Hamel E; Lee DJ; Pryor DE; Cushman M
J Med Chem; 2003 Apr; 46(9):1670-82. PubMed ID: 12699385
[TBL] [Abstract][Full Text] [Related]
13. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical design of antimitotic agents based on combretastatins.
Hsieh HP; Liou JP; Mahindroo N
Curr Pharm Des; 2005; 11(13):1655-77. PubMed ID: 15892667
[TBL] [Abstract][Full Text] [Related]
15. Structural requirements for the interaction of combretastatins with tubulin: how important is the trimethoxy unit?
Gaukroger K; Hadfield JA; Lawrence NJ; Nolan S; McGown AT
Org Biomol Chem; 2003 Sep; 1(17):3033-7. PubMed ID: 14518125
[TBL] [Abstract][Full Text] [Related]
16. New naphthylcombretastatins. Modifications on the ethylene bridge.
Sánchez Maya AB; Pérez-Melero C; Salvador N; Peláez R; Caballero E; Medarde M
Bioorg Med Chem; 2005 Mar; 13(6):2097-107. PubMed ID: 15727863
[TBL] [Abstract][Full Text] [Related]
17. Regioselective Suzuki coupling of dihaloheteroaromatic compounds as a rapid strategy to synthesize potent rigid combretastatin analogues.
Theeramunkong S; Caldarelli A; Massarotti A; Aprile S; Caprioglio D; Zaninetti R; Teruggi A; Pirali T; Grosa G; Tron GC; Genazzani AA
J Med Chem; 2011 Jul; 54(14):4977-86. PubMed ID: 21696175
[TBL] [Abstract][Full Text] [Related]
18. Chemistry and folding of photomodulable peptides--stilbene and thioaurone-type candidates for conformational switches.
Erdélyi M; Varedian M; Sköld C; Niklasson IB; Nurbo J; Persson A; Bergquist J; Gogoll A
Org Biomol Chem; 2008 Dec; 6(23):4356-73. PubMed ID: 19005595
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N
J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activity of naphthalene analogues of phenstatins: naphthylphenstatins.
Alvarez C; Alvarez R; Corchete P; Pérez-Melero C; Peláez R; Medarde M
Bioorg Med Chem Lett; 2007 Jun; 17(12):3417-20. PubMed ID: 17434303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
